Fibromyalgia syndrome is a rheumatic disorder characterized by widespread musculoskeletal pain, morning stiffness, fatigue and the presence of multiple tender points in the body. The prevalence has been reported to be 1.7% in the general population. This condition predominantly affects women, with a female:male ratio of 13.7:1 ([@b1-prm-20-137]). Fibromyalgia syndrome causes a significant decrease in functional capacity and represents a barrier to maintaining daily activities of life by interfering with the social functioning of an individual ([@b2-prm-20-137]). Fibromyalgia is frequently comorbid with other conditions, such as irritable bowel syndrome, dysmenorrhea, temporomandibular joint disorders, chronic fatigue syndrome, migraine, restless leg syndrome and affective disorders, all of which are believed to be involved in central sensitization ([@b3-prm-20-137]--[@b5-prm-20-137]).

Dyspareunia is defined by the American College of Obstetricians and Gynecologists as genital pain experienced immediately before, during or after sexual intercourse ([@b6-prm-20-137]). Dyspareunia is categorized as superficial and deep. Pain during sexual intercourse can be felt around the vagina and in the pelvic region ([@b7-prm-20-137]). The prevalence of dyspareunia is reported to range from 8% to 21% ([@b8-prm-20-137]). Acute somatic pain developing in association with dyspareunia is considered to induce peripheral sensitization, which, in turn, causes neuropathic pain through central sensitization ([@b9-prm-20-137]). Provoked vestibulodynia is one of the most common causes of dyspareunia in women. An increase in the number of painful spots in patients with vulvar vestibulitis ([@b10-prm-20-137]) and hyperactivity in the same brain areas on stimulation with pressure in patients with vulvodynia and fibromyalgia have suggested a possible relationship between dyspareunia and fibromyalgia ([@b11-prm-20-137]).

The aim of the present study was to evaluate women with or without dyspareunia in terms of the number of tender points, pressure pain threshold and presence of fibromyalgia.

METHODS
=======

The Institutional Review Board of Kocaeli University Faculty of Medicine (Kocaeli, Turkey) approved the study protocol. The study participants were selected among patients who were admitted to the gynecology clinic. Patients who were admitted to the gynecology clinic were questioned by the same gynecologist for the presence of dyspareunia. The present cross-sectional study involved 40 patients with dyspareunia and 30 healthy controls. Women between 18 and 45 years of age who were sexually active and had a partner were included. Women with a known disease that could cause dyspareunia and those with a history of gynecological surgery, a major medical or psychotic disorder, and pregnant women were excluded from the study. A detailed medical history was obtained, and all patients underwent a physical examination. The demographic data, habits (alcohol use and smoking), medications and gynecological history were recorded for all patients. All participants were evaluated for depression, pressure pain threshold and fibromyalgia. The diagnosis of fibromyalgia was established by 1990 American College of Rheumatology ([@b12-prm-20-137]) diagnostic criteria.

Diagnosis of dyspareunia
------------------------

Participants were asked whether they had engaged in sexual intercourse during the previous four weeks and dyspareunia was rated on a four-point scale, ranging from 0 to 3, using the Marinoff Dyspareunia Scale ([@b13-prm-20-137]): 0 = no dyspareunia; 1 = causes discomfort, but does not interfere with the frequency of intercourse; 2 = sometimes prevents intercourse; and 3 = completely prevents intercourse.

The severity of dyspareunia was assessed using a visual analogue scale (VAS), with 0 indicating no pain and 10 indicating severe pain.

Pressure pain threshold
-----------------------

A pressure algometer (dolorimeter; Baseline FDK, Fabrication Enterprises, USA) was used to measure pressure pain threshold. The algometer used in the present study consisted of a metal probe with a round rubber disc (1 cm diameter) at one end; the probe was attached to a scale that can measure pressure in kilograms and pounds. The operator can apply pressure to the desired muscle by holding the scale. The pressure applied by pressing the rubber disc to the skin perpendicularly moves the needle in the scale clockwise through the metal probe. For pressure pain measurement in the present study, 18 bilateral tender points (insertion of the suboccipital muscle, upper midpoint of the trapezius muscle, origin of the supraspinatus muscle, lower part of the sternocleidomastoid muscle, second costochondral junction, 2 cm distal to the lateral epicondyle, upper lateral part of the gluteal region, surface of the greater trochanter and the medial fat pad of the knee) described in the 1990 American College of Rheumatology criteria for fibromyalgia ([@b12-prm-20-137]), and four generally accepted control points used in many previous studies (thumb, nail, and volar side of the forearm bilaterally) ([@b14-prm-20-137]) were used.

All tender points were marked. The palpation and dolorimetric measurements were performed by the same physician. The 18 tender points were palpated with approximately 4 kg/cm^2^ of pressure with the thumb (just enough to blanch the examiner's thumb) and painful points were recorded. The total number of painful points was calculated for each patient.

Using the pressure algometer, pressure was applied on the 18 paired tender points and four control points. The pressure was increased by 1 kg/s, and the first pressure value that the patient perceived pain was recorded in kg/cm^2^ units. The sum of painful pressures in kilograms (tender points) was recorded as the myalgic score, and the sum of painful pressures in kilograms in the four control points was recorded as the control point score. The mean tender point pressure pain threshold was calculated by dividing the sum of minimal pressure that induced pain during dolorimetric measurement in the tender points to the number of painful points.

Depression
----------

The depression status of the patients was assessed via the Beck Depression Inventory. The Beck Depression Inventory is a self-reported depression scale with 21 items. The scores range from 0 to 63; higher scores indicate more severe depression. The scores were evaluated as follows: 0 to 13 = no depression, 14 to 24 = mild depression and \>25 = severe depression ([@b15-prm-20-137]).

Statistical analysis
--------------------

Data were reported as mean ± SD. The parametric data of the patients were compared through a *t* test and the nonparametric data were compared through a χ^2^ test. The level of statistical significance was set at P\<0.05.

RESULTS
=======

The mean (± SD) age of the patients with dyspareunia included in the study was 38.7±3.2 years, and the mean age of the control group was 39.2±4.1 years. No statistically significant differences were observed with regard to age, body mass index, habits, educational status and occupational status between the two groups (P\>0.05) ([Table 1](#t1-prm-20-137){ref-type="table"}).

The mean duration of dyspareunia was 16.3±5.1 months. Dyspareunia was identified as grade 1 in 12 patients, grade 2 in 12 patients and grade 3 in 16 patients. Total myalgic score, total control score and tender point mean pain threshold were significantly lower in the group with dyspareunia. The tender point count was significantly higher in the group with dyspareunia. The Beck Depression Inventory score was 14.7±8.4 in the dyspareunia group compared with 11.2±7.1 in the control group. The difference was not statistically significant ([Table 1](#t1-prm-20-137){ref-type="table"}).

Five (12.5%) of the patients with dyspareunia were diagnosed with fibromyalgia, whereas no patients in the control group were diagnosed with fibromyalgia. The diagnosis of fibromyalgia was established in the presence of widespread body pain for ≥3 months (right and left side of the body, below and above the waist, and axial pain) and presence of tenderness during palpation on ≥11 of 18 tender points with approximately 4 kg pressure (just enough to blanch the nail of the thumb). There was no significant difference between the two groups in terms of the presence of fibromyalgia (P=0.09).

The mean age of the group with dyspareunia and fibromyalgia was 38.9±2.1 years, compared with 38.7±2.3 years in the group with dyspareunia but without fibromyalgia. The difference between the groups in terms of age was not statistically significant (P=0.14). The mean Beck Depression Inventory score was 18.1±6.7 in the dyspareunia group with fibromyalgia compared with 11.3±4.1 in the dyspareunia group without fibromyalgia. The difference was statistically significant (P=0.03). There was no significant difference between the groups with regard to dyspareunia grade (P=0.2). The mean dyspareunia VAS score was 6.02±2.1 in patients with fibromyalgia and 4.12±1.1 in patients without fibromyalgia. There was a significant difference in dyspareunia VAS scores between the two groups (P=0.04) ([Table 2](#t2-prm-20-137){ref-type="table"}).

DISCUSSION
==========

In the present study, pressure pain threshold was lower at the tender and control points in the patients with dyspareunia, and fibromyalgia was identified at a higher rate in these patients. The depression scores were significantly higher in patients with dyspareunia diagnosed with fibromyalgia compared with patients with dyspareunia without fibromyalgia.

Studies reported in the literature indicate that patients with dyspareunia are more sensitive to pain and tactile stimuli in the genital area ([@b10-prm-20-137],[@b16-prm-20-137]), and there are structural and functional abnormalities in the peripheral sensory nerves, especially in the vestibular and vulvar tissues ([@b17-prm-20-137]). The peripheral sensitization in some patients is considered to induce a central sensitization over time ([@b18-prm-20-137]). Thus, pain sensitivity in some patients may generalize to nongenital parts of the body ([@b16-prm-20-137],[@b19-prm-20-137]). Provoked vestibulodynia characterized by chronic and painful inflammation of vestibular structures is one of the most common causes of dyspareunia ([@b20-prm-20-137]).

Pukall et al ([@b21-prm-20-137]) evaluated 16 vulvar vestibulitis patients with genital pain and 16 control women in terms of generalized pain sensitivity. The tender points used to diagnose fibromyalgia were used in the evaluation. More tender points were identified in women with vulvar vestibulitis compared with the control group. Furthermore, these patients also described a considerably higher level of pain and discomfort. Thus, the results of this study indicate that the development of vulvar vestibulitis may involve mechanisms that are not limited to the genitals, and that these mechanisms may have more a centralized nature ([@b21-prm-20-137]). In a study conducted by Granot et al ([@b22-prm-20-137]), heat pain was administered to the forearms of patients to determine thresholds for pain and discomfort, and to also assess the perceived level of pain and discomfort associated with suprathreshold stimuli. This study demonstrated lower thresholds for pain and discomfort among vulvar vestibulitis patients, as well as a suprathreshold for perceived pain and discomfort that was 13 times greater than that of the controls ([@b22-prm-20-137]). In the present study, the pressure pain threshold at tender and control points was lower in patients with dyspareunia than it was in patients in the control group, as is the case in fibromyalgia. This finding suggests that pain sensitivity may not be solely limited to the genital area in these patients; some central mechanisms may be involved in its etiology and there are diffuse interactions in pain modulation. There are a few morphological and functional studies that have investigated the brain with the hypothesis that central mechanisms may be involved in dyspareunia. In vulvar vestibulitis patients with genital pain, activation was identified on functional brain magnetic resonance imaging at the central pain centre, which was similar to conditions with chronic pain such as fibromyalgia, irritable bowel syndrome and chronic low back pain ([@b23-prm-20-137]). In studies that used brain imaging techniques to investigate pain in patients with vulvodynia, the density of grey matter increased in the brain areas associated with pain modulation and stress ([@b24-prm-20-137]). The presence of some central mechanisms in dyspareunia that are similar to some of the central mechanisms in fibromyalgia supports the coexistence of these two conditions.

Depression scores were significantly higher in the dyspareunia patients diagnosed with fibromyalgia. Studies in the literature have reported a positive correlation between the painful conditions and the severity of pain and depression ([@b25-prm-20-137]). Similarly, the co-occurrence of two painful conditions -- fibromyalgia and dyspareunia -- may have led to higher depression scores in the present study.

In the present study, the presence of dyspareunia was assessed only in the previous four weeks. One study limitation was that patients who avoided frequent sexual intercourse due to dyspareunia were not evaluated in this group of patients. Furthermore, pressure pain threshold in the vulvar region was not evaluated. Further studies are required in this regard. Other limitations of the present study include the small patient population, and lack of electrophysiological and brain imaging studies, which provide more objective data about the presence of central mechanisms.

CONCLUSION
==========

The pressure pain threshold was lower in patients with dyspareunia compared with the control group. The prevalence of fibromyalgia was analyzed in patients with dyspareunia. Patients with dyspareunia and fibromyalgia should be examined for depression. Additional studies involving a greater number of patients are required to investigate the presence of central mechanisms in the pathogenesis of dyspareunia.
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###### 

Comparison of groups with or without dyspareunia

                                     **Dyspareunia (n=40)**   **Control group (n=30)**   **P**
  ---------------------------------- ------------------------ -------------------------- ---------------------------------------------------
  Age, years                         38.7±3.2.                39.2±4.1                   0.5
  Body mass index, kg/m^2^           27.5±5.2                 28.3±4.01                  0.6
  Current smoker, n (%)              29 (50)                  14 (47)                    0.1
  Education level, n (%)                                                                 
    Elementary school                10 (25)                  7 (23.3)                   0.6
    High school                      15 (37.5)                12 (40)                    
    University                       15 (37.5)                11 (36.7)                  
  Employment, n (%)                                                                      
    Housewife                        20 (50)                  16 (53.3)                  0.1
    Employed                         20 (50)                  14 (46.7)                  
  Beck Depression Inventory score    14.7±8.4                 11.2±7.1                   0.1
  Total myalgic score, g/cm^2^       133.2±18.6               164.2±9.2                  0.02^[\*](#tfn2-prm-20-137){ref-type="table-fn"}^
  Total control score, g/cm^2^       22.4±3.7                 27.5±3.4                   0.03^[\*](#tfn2-prm-20-137){ref-type="table-fn"}^
  Tender point count                 4.7±3.5                  1.5±1.1                    0.01^[\*](#tfn2-prm-20-137){ref-type="table-fn"}^
  Tender point mean pain threshold   2.8±0.54                 3.9±1.0                    0.03^[\*](#tfn2-prm-20-137){ref-type="table-fn"}^

Data presented as mean ± SD unless otherwise indicated.

Statistically significant (P\<0.05)

###### 

Grade of dyspareunia and pain scores according to the presence of fibromyalgia in patients with dyspareunia

  **Variable**                             **Dyspareunia**   **P**       
  ---------------------------------------- ----------------- ----------- ---------------------------------------------------
  Age, years, mean ± SD                    38.9±2.1          38.7±2.3    0.1
  Marinoff Dyspareunia Scale                                             
    Grade 1                                1 (20)            11 (31.4)   0.2
    Grade 2                                2 (40)            10 (28.6)   
    Grade 3                                2 (40)            14 (40)     
  Visual analogue scale score, mean ± SD   6.02±2.1          4.12±1.1    0.04^[\*](#tfn4-prm-20-137){ref-type="table-fn"}^

Data presented as n (%) unless otherwise indicated.

Statistically significant (P\<0.05). + With; − Without
